Skip to main content
Contact Us
Subscribe
E-Edition
71°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geron Corp
(NQ:
GERN
)
4.250
-0.040 (-0.93%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Geron Corp
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
March 30, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
March 29, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 17, 2022
From
Geron Corporation
Via
Business Wire
Recap: Geron Q4 Earnings
March 10, 2022
Geron (NASDAQ:GERN) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Geron missed...
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
Geron's Earnings: A Preview
March 09, 2022
Geron (NASDAQ:GERN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
Via
Benzinga
32 Stocks Moving in Friday's Pre-Market Session
February 25, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) rose 54.6% to $7.48 in pre-market trading after gaining around 119% on Thursday. The company recently announced a $12 million private placement...
Via
Benzinga
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference
January 21, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at the H.C. Wainwright BioConnect Conference
January 04, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 16, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Presentations at American Society of Hematology Annual Meeting
December 14, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Appointment of Chief Business Officer
December 02, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 18, 2021
From
Geron Corporation
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 17, 2021
Gainers Rani Therapeutics Hldgs (NASDAQ:RA...
Via
Benzinga
Geron to Present at the Stifel 2021 Virtual Healthcare Conference
November 12, 2021
From
Geron Corporation
Via
Business Wire
30 Stocks Moving in Wednesday's Pre-Market Session
November 10, 2021
Gainers RenovoRx, Inc. (NASDAQ: RNXT) rose 113% to $11.50 in pre-market trading. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a...
Via
Benzinga
Geron Presents Investor Event Highlights
November 09, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting
November 04, 2021
From
Geron Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021
November 02, 2021
Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 01, 2021
Gainers Biophytis (NASDAQ:BPTS) shares mo...
Via
Benzinga
Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat
October 25, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 21, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
October 18, 2021
From
Geron Corporation
Via
Business Wire
Geron to Host a Virtual Investor Event in November
October 15, 2021
From
Geron Corporation
Via
Business Wire
15 Stocks Moving in Tuesday's Pre-Market Session
October 12, 2021
Gainers Quanterix Corporation (NASDAQ: QTRX) shares rose 17.6% to $48.55 in pre-market trading after the company announced its Simoa phospho-Tau 181 blood test has been granted...
Via
Benzinga
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology
October 11, 2021
From
Geron Corporation
Via
Business Wire
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
Geron Earnings Perspective: Return On Capital Employed
October 04, 2021
Benzinga Pro data, Geron (NASDAQ:GERN) reported Q2 sales of $107.00 thousand. Earnings fell to a loss of $28.89 million, resulting in a 1.53% decrease from last quarter. Geron...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.